Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chalazion × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 226 Rectal Neoplasms 139 Pancreatic Neoplasms 112 Stomach Neoplasms 97 Colonic Neoplasms 97 Esophageal Neoplasms 81 Neoplasm Metastasis 61 Breast Neoplasms 54 Squamous Cell Carcinoma of Head and Neck 41 Carcinoma, Hepatocellular 40 Adenocarcinoma Of Esophagus 37 Neoplasms 35 Head and Neck Neoplasms 35 Esophageal Squamous Cell Carcinoma 35 Nasopharyngeal Carcinoma 29 Adenocarcinoma 23 Cholangiocarcinoma 18 Keratosis, Actinic 17 Carcinoma, Squamous Cell 16 Biliary Tract Neoplasms 16 Liver Neoplasms 15 Gastrointestinal Neoplasms 14 Anus Neoplasms 13 Gallbladder Neoplasms 11 Bile Duct Neoplasms 11 Peritoneal Neoplasms 8 Recurrence 7 Nasopharyngeal Neoplasms 7 Laryngeal Neoplasms 7 Mouth Neoplasms 6

Interventions

Conservative Treatment 3 Probiotics 2 Curettage 2 Triamcinolone Acetonide 1 Triamcinolone 1 Tetracycline 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡